<DOC>
	<DOCNO>NCT00834834</DOCNO>
	<brief_summary>This study compare effectiveness two treatment , dialectical behavior therapy versus fluoxetine clinical management , reduce risk self-injury suicidal behavior people borderline personality disorder .</brief_summary>
	<brief_title>Comparing Treatments Self-Injury Suicidal Behavior People With Borderline Personality Disorder</brief_title>
	<detailed_description>Borderline personality disorder ( BPD ) chronic disorder emotional regulation characterize instability self-image , mood , relationship , behavior . People suffer BPD high rate self-injury suicide attempt . This study compare effectiveness two treatment prevent self-injury suicide people BPD : dialectical behavior therapy ( DBT ) fluoxetine clinical management . DBT behavioral therapy teach new cop skill replace old strategy , include self-injury attempt suicide . Fluoxetine selective serotonin reuptake inhibitor ( SSRI ) medication use treat BPD . Clinical management fluoxetine , involve administer medication normal condition , refers regular visit psychiatrist monitor medication effectiveness side effect . Clinical management study may include adjust dosage fluoxetine prescribe change medication citalopram , another SSRI . Participation study last 12 month , include follow-up assessment . During first study visit , participant undergo baseline test randomly assign receive either DBT fluoxetine clinical management . After washout period , participant transition medication currently take , participant receive 6 month assign treatment . Participants receive DBT attend one 60-minute individual therapy session one 90-minute group session every week . Participants assign fluoxetine clinical management condition begin receive 20 mg fluoxetine daily dose increase course 4 week , base tolerance , 40 mg . Participants assign fluoxetine may also switch citalopram , study psychiatrist think effective . Participants assign either fluoxetine citalopram undergo monthly blood test monitor level medication body . Every 2 week , participant undergo assessment treatment effectiveness side effect . After 2 , 4 , 6 , 9 , 12 month , participant undergo various neuropsychological test clinical interview self-report questionnaire mood life experience . At study entry Weeks 12 24 , participant use handheld computer complete week-long assessment emotion . Fully healthy female participant ask complete functional magnetic resonance imaging ( fMRI ) scan , assess ability regulate emotion neural level . The fMRI scan stress test ( men woman ) perform baseline 6 month .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Suicide</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Meets DSMIV criterion borderline personality disorder ( BPD ) Attempted suicide past 2 month At least one additional suicide attempt , suiciderelated behavior , selfinjury episode past year Current suicidal ideation Able manage outpatient Not currently receive optimum psychiatric treatment agree notify study staff psychiatric care outside study seek . If care permit protocol utilized , participant longer enrol study . Has stable living arrangement study entry Speaks English Willing judge clinically able undergo washout psychotropic medication , except occasional benzodiazepine use , 2 6 week treatment Females must willing use effective method birth control . Meets DSMIV criterion mental retardation follow disorder : bipolar I , schizophrenia , delusional disorder , schizophreniform disorder , schizoaffective disorder , psychotic disorder otherwise specify ( NOS ) Needs priority treatment acute medical illness debilitating problem , severe substance dependence anorexia Pregnant Clinically unstable maintain outpatient Has clearly fail adequate trial fluoxetine citalopram major depression past 2 year History severe allergy , adverse drug reaction , know allergy fluoxetine citalopram Clinically inadvisable participant end current treatment Heart pacemaker body implant ; metal implant , shrapnel surgical prosthesis ; paramagnetic object contain within body , assess via metal screen questionnaire , may present risk participant interfere fMRI scan Diagnosed Raynaud 's disorder History hypertension , cardiovascular disease , abnormal electrocardiogram ( EKGs ) Claustrophobia significant discomfort enclose space</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Suicidal Self-Injurious Behavior</keyword>
</DOC>